Insulin Detemir: A Twice-Daily Background Insulin
A background insulin that often does not last a full day, which is a feature rather than a failing.
Sometimes you know the condition but not the medicine, or you have been handed something and want to understand why this one rather than another. These guides start from the condition and work outwards to the treatments usually used for it, and the reasoning behind the order they are normally tried in.
A background insulin that often does not last a full day, which is a feature rather than a failing.
It only works where it makes contact, which means how you use it decides whether it works at all.
One common antibiotic raises its levels roughly tenfold, and the combination is flatly contraindicated.
Two salts with different strengths, and a combination product that causes more problems than it solves.
A tablet that can end an episode within hours, and a drug that is dangerous in the wrong heart.
The long half-life that makes it steady during treatment is the same thing that makes coming off it a slow business.
No sedation, no dependence and no immediate effect, which is why people expecting a benzodiazepine are disappointed.
It stops working as a sleep aid within about a week, and what it keeps doing is the part worth worrying about.
The same drug in two forms with entirely different risk: one taken off the shelf, one still on it.
A tablet that works as well as an injected biologic, with restrictions that changed after one large trial reported.
It targets the allergic pathway rather than suppressing immunity broadly, which changes what has to be monitored.
It sits between the two other calcium channel blockers in almost every respect, including which brand you get.